BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18728311)

  • 1. Process control analysis of IMRT QA: implications for clinical trials.
    Pawlicki T; Yoo S; Court LE; McMillan SK; Rice RK; Russell JD; Pacyniak JM; Woo MK; Basran PS; Boyer AL; Bonilla C
    Phys Med Biol; 2008 Sep; 53(18):5193-205. PubMed ID: 18728311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving from IMRT QA measurements toward independent computer calculations using control charts.
    Pawlicki T; Yoo S; Court LE; McMillan SK; Rice RK; Russell JD; Pacyniak JM; Woo MK; Basran PS; Shoales J; Boyer AL
    Radiother Oncol; 2008 Dec; 89(3):330-7. PubMed ID: 18701175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience.
    Georg D; Stock M; Kroupa B; Olofsson J; Nyholm T; Ahnesjö A; Karlsson M
    Phys Med Biol; 2007 Aug; 52(16):4981-92. PubMed ID: 17671348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
    Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
    Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
    Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.
    Johansson KA; Nilsson P; Zackrisson B; Ohlson B; Kjellén E; Mercke C; Alvarez-Fonseca M; Billström A; Björk-Eriksson T; Björ O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Löfroth PO; Löfvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand HO; Wiklund F; Wittgren L
    Radiother Oncol; 2008 May; 87(2):290-9. PubMed ID: 18206256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins.
    Suzuki M; Nishimura Y; Nakamatsu K; Okumura M; Hashiba H; Koike R; Kanamori S; Shibata T
    Radiother Oncol; 2006 Mar; 78(3):283-90. PubMed ID: 16564594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical application of an automated phantom-film QA procedure for validation of IMRT treatment planning and delivery.
    Kapulsky A; Gejerman G; Hanley J
    Med Dosim; 2004; 29(4):279-84. PubMed ID: 15528070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer.
    Vaarkamp J; Malde R; Dixit S; Hamilton CS
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):310-7. PubMed ID: 19624299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a 2D diode array for IMRT quality assurance.
    Létourneau D; Gulam M; Yan D; Oldham M; Wong JW
    Radiother Oncol; 2004 Feb; 70(2):199-206. PubMed ID: 15028408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensity modulated radiotherapy (IMRT) in France: The boost of the national funding for the new expensive innovative technologies (STIC 2001 and 2002)].
    Marchal C; Bensadoun RJ; Haslé E; Lapeyre M; Carrere MO; Gérard JP
    Cancer Radiother; 2003 Nov; 7 Suppl 1():44s-48s. PubMed ID: 15124543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an objective evaluation of tolerances for beam modeling in a treatment planning system.
    Rangel A; Ploquin N; Kay I; Dunscombe P
    Phys Med Biol; 2007 Oct; 52(19):6011-25. PubMed ID: 17881816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
    Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
    Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for a head and neck IMRT quality assurance protocol].
    Zefkili S; Tomsej M; Aletti P; Bidault F; Bridier A; Marchesi V; Marcié S
    Cancer Radiother; 2004 Dec; 8(6):364-79. PubMed ID: 15619381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer.
    Boehmer D; Bohsung J; Eichwurzel I; Moys A; Budach V
    Radiother Oncol; 2004 Jun; 71(3):319-25. PubMed ID: 15172148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of IMRT planning with two-step and one-step optimization: a way to simplify IMRT.
    Ludlum E; Xia P
    Phys Med Biol; 2008 Feb; 53(3):807-21. PubMed ID: 18199916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of direct aperture optimization when applied to head-and-neck IMRT.
    Jones S; Williams M
    Med Dosim; 2008; 33(1):86-92. PubMed ID: 18262129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries?
    Koh WY; Ren W; Mukherjee RK; Chung HT
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1447-54. PubMed ID: 19250761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement.
    Adams EJ; Convery DJ; Cosgrove VP; McNair HA; Staffurth JN; Vaarkamp J; Nutting CM; Warrington AP; Webb S; Balyckyi J; Dearnaley DP
    Radiother Oncol; 2004 Jan; 70(1):1-10. PubMed ID: 15036846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.